Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) is a biotechnology company that has carved a niche in the burgeoning field of synthetic biology. Based in Boston, Massachusetts, Ginkgo is at the..
Cel-Sci Corporation (NYSE: CVM) is capturing the attention of investors with its promising biotechnology portfolio and significant potential upside. Despite a modest market capitalization of $48.92 million, Cel-Sci’s stock is..
Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX), a biopharmaceutical company based in Cambridge, Massachusetts, is capturing the attention of investors with a promising upside potential of nearly 50%. Specializing in developing treatments..
In the dynamic world of biotechnology, Oruka Therapeutics, Inc. (NASDAQ: ORKA) is carving out a significant niche. With a focused approach on developing monoclonal antibody therapeutics for conditions like psoriasis..
MeiraGTx Holdings plc (MGTX) presents a captivating opportunity for investors who are willing to navigate the complex landscape of biotechnology investments. With a focus on genetic medicines targeting serious diseases,..
Personalis, Inc. (NASDAQ: PSNL) is a healthcare company with a strong foothold in the diagnostics and research industry. Headquartered in Fremont, California, Personalis is renowned for its advanced genomic tests,..
Verastem, Inc. (NASDAQ: VSTM), a development-stage biopharmaceutical company based in Needham, Massachusetts, is garnering significant attention from investors and analysts alike, with a strong buy consensus and a promising pipeline..
EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) stands out in the biotechnology industry with a compelling investment narrative, driven by its innovative approach to treating retinal diseases. Based in Watertown, Massachusetts, EyePoint..
Eton Pharmaceuticals, Inc. (NASDAQ: ETON), a company at the forefront of developing treatments for rare diseases, presents an intriguing investment opportunity with its impressive growth trajectory and significant market potential...
Autolus Therapeutics plc (NASDAQ: AUTL) is garnering significant attention on the investment front, especially with its remarkable potential upside of 683.20%. As a clinical-stage biopharmaceutical company, Autolus is at the..
Tilray Brands, Inc. (NASDAQ: TLRY) is a prominent name in the cannabis industry, engaging in the research, cultivation, processing, and distribution of medical cannabis products across various global markets. Despite..
COMPASS Pathways Plc (NASDAQ: CMPS), a pioneering biotechnology firm, is capturing the attention of investors with its significant potential upside. With a current market capitalization of $499.29 million, the company’s..
Surmodics, Inc. (NASDAQ: SRDX), a prominent player in the healthcare sector, specializes in medical devices and in vitro diagnostics (IVD), offering a range of performance coating technologies. While Surmodics has..
Relay Therapeutics, Inc. (NASDAQ: RLAY) is making waves in the biotechnology sector with its innovative approach to drug discovery. As a clinical-stage precision medicines company, Relay Therapeutics is focused on..
Abivax SA (ABVX) has made remarkable strides in the biotechnology sector, capturing the attention of investors with its impressive market cap of $9.82 billion. The Paris-based clinical-stage biotech company is..
For investors looking for high-risk, high-reward opportunities in the healthcare sector, Akebia Therapeutics, Inc. (NASDAQ: AKBA) has emerged as a compelling candidate. The biopharmaceutical company, headquartered in Cambridge, Massachusetts, specializes..
PureTech Health plc (PRTC) may not be a household name in the biotech sector, but its remarkable 542.7% revenue growth is a figure that demands investor attention. With a market..
Organogenesis Holdings Inc. (NASDAQ: ORGO) stands as a compelling player in the healthcare sector, specifically within the niche of regenerative medicine. With a market capitalization of approximately $649.79 million, this..
For investors with an appetite for high-risk, high-reward opportunities, Humacyte, Inc. (NASDAQ: HUMA) presents a compelling case. With a market cap of approximately $209.74 million, this biotechnology firm is making..
Sionna Therapeutics, Inc. (NASDAQ: SION), a biopharmaceutical innovator in the healthcare sector, is capturing attention with its focused mission to develop groundbreaking treatments for cystic fibrosis (CF). With a current..
